British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

PD Lambiase, Bono JP de, RJ Schilling, M Lowe, A Turley, A Slade, J Collinson, K Rajappan, S Harris, J Collison, V Carpenter, H Daw, A Hall, D Taylor

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

The British Heart Rhythm Society’s Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication are written for heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists who may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or proven. The guidance is adapted from the latest Maudsley Prescribing Guidelines in Psychiatry, published in 2018.
Original languageEnglish
Pages (from-to)161-165
JournalArrhythmia & electrophysiology review
Volume8
Issue number3
DOIs
Publication statusPublished - 1 Jul 2019

Keywords

  • Antipsychotic medication
  • schizophrenia
  • QT prolongation
  • guidelines
  • psychiatry

Fingerprint

Dive into the research topics of 'British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.'. Together they form a unique fingerprint.

Cite this